Cogent Biosciences Inc.

8.68+0.0400+0.46%Vol 589.09K1Y Perf 439.38%
Apr 13th, 2021 15:43 DELAYED
BID8.67 ASK8.69
Open8.64 Previous Close8.64
Pre-Market- After-Market-
 - -%  - -
Target Price
20.67 
Analyst Rating
— — 0.00
Potential %
137.59 
Finscreener Ranking
★★★     51.11
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★     47.72
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
★★★     51.83
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap322.84M 
Earnings Rating
Strong Sell
Price Range Ratio 52W %
54.01 
Earnings Date
10th May 2021

Today's Price Range

8.458.79

52W Range

1.4014.88

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Sell
Performance
1 Week
0.82%
1 Month
5.62%
3 Months
-27.82%
6 Months
-25.26%
1 Year
439.38%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
COGT8.680.04000.46
AAPL134.473.23002.46
GOOG2 269.8015.01000.67
MSFT258.352.44000.95
XOM55.670.17000.31
WFC39.79-0.9800-2.40
JNJ159.43-2.2100-1.37
FB310.18-1.3600-0.44
GE13.49-0.1000-0.74
JPM154.24-1.7100-1.10
Financial StrengthValueIndustryS&P 500US Markets
18.50
18.70
0.01
0.04
-
Leverage Ratio 2.00
ProfitabilityValueIndustryS&P 500US Markets
-
-295.80
-291.40
-407.40
-48.98
RevenueValueIndustryS&P 500US Markets
840.00K
0.02
5.33
-12.34
Earnings HistoryEstimateReportedSurprise %
Q04 2020-0.30-6.03-1 910.00
Q03 2020-0.19-0.26-36.84
Q02 2020-0.84-0.96-14.29
Q01 2020-1.32-0.8039.39
Q04 2019-1.400.28120.00
Q03 2019-1.24-1.56-25.81
Q02 2019-0.39-0.3412.82
Q01 2019-0.31-0.39-25.81
Earnings Per EndEstimateRevision %Trend
3/2021 QR-0.46-43.75Negative
6/2021 QR-0.58-28.89Negative
12/2021 FY-1.96-44.12Negative
12/2022 FY-1.74-10.83Negative
Next Report Date10th May 2021
Estimated EPS Next Report-0.46
Estimates Count5
EPS Growth Next 5 Years %-
Volume Overview
Volume589.09K
Shares Outstanding37.19M
Trades Count2.83K
Dollar Volume4.19M
Avg. Volume406.04K
Avg. Weekly Volume392.25K
Avg. Monthly Volume351.15K
Avg. Quarterly Volume419.73K

Cogent Biosciences Inc. (NASDAQ: COGT) stock closed at 8.64 per share at the end of the most recent trading day (a 4.22% change compared to the prior day closing price) with a volume of 628.87K shares and market capitalization of 322.84M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 72 people. Cogent Biosciences Inc. CEO is Andrews R. Robbins.

The one-year performance of Cogent Biosciences Inc. stock is 439.38%, while year-to-date (YTD) performance is -23.06%. COGT stock has a five-year performance of %. Its 52-week range is between 1.4 and 14.88, which gives COGT stock a 52-week price range ratio of 54.01%

Cogent Biosciences Inc. currently has a PE ratio of -0.50, a price-to-book (PB) ratio of 2.50, a price-to-sale (PS) ratio of 382.57, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -119.34%, a ROC of -661.35% and a ROE of -230.42%. The company’s profit margin is -48.98%, its EBITDA margin is -291.40%, and its revenue ttm is $840.00 Thousand , which makes it $0.02 revenue per share.

Of the last four earnings reports from Cogent Biosciences Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-0.46 for the next earnings report. Cogent Biosciences Inc.’s next earnings report date is 10th May 2021.

The consensus rating of Wall Street analysts for Cogent Biosciences Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Cogent Biosciences Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cogent Biosciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Cogent Biosciences Inc. has a Neutral technical analysis rating based on Technical Indicators (ADX : 22.15, ATR14 : 0.68, CCI20 : -48.08, Chaikin Money Flow : 0.27, MACD : -0.54, Money Flow Index : 34.01, ROC : 0.12, RSI : 45.13, STOCH (14,3) : 46.75, STOCH RSI : 1.00, UO : 55.99, Williams %R : -53.25), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cogent Biosciences Inc. in the last 12-months were: John L. Green (Option Excercise at a value of $0)

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary Rating---

Cogent Biosciences Inc.

Cogent Biosciences Inc is a biotechnology company. The company is engaged in the development of solutions to treat genetically driven diseases.

CEO: Andrews R. Robbins

Telephone: +1 617 945-5576

Address: 200 Cambridge Park Drive, Cambridge 02140, MA, US

Number of employees: 72

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

57%43%

Bearish Bullish

52%48%

Bearish Bullish

46%54%

News

Stocktwits